Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182

<table>(a) reduction using chiral catalytic reagent or biocatalytic process; (b) base; (c) amine.</table>

Enzyme Research

sch1

Scheme 1

Scheme 1: Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182 

Scheme 1 | Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and 
                        Rhodotorula glutinis  CCT 2182 

Enzyme Research

Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182

Scheme 1